Yuki Yamanishi

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

David Adams, Michael Polydefkis, Alejandra González‐Duarte et al. · The Lancet Neurology · 2020 · 154 citations · Full text

Alzheimer's Disease, Open-label Extension Study, Medicine +5

Synthesis of glycerol carbonate from glycerol and urea using zinc-containing solid catalysts: A homogeneous reaction

Shin‐ichiro Fujita, Yuki Yamanishi, Masahiko Arai · Journal of Catalysis · 2012 · 111 citations

Chemical Engineering, Catalytic Application, Engineering +8

Clinical variability associated with intronic <i>FGF14</i> GAA repeat expansion in Japan

Masahiro Ando, Yujiro Higuchi, Jun‐Hui Yuan et al. · Annals of Clinical and Translational Neurology · 2023 · 28 citations · Full text

A comparative study of monoaminergic involvement in the antinociceptive action of E-2078, morphine and U-50,488E.

Takanobu Nakazawa, Yuki Yamanishi, Takeshi Kaneko · Journal of Pharmacology and Experimental Therapeutics · 1991 · 25 citations

A double-blind, randomized controlled trial of duloxetine for pain in Parkinson's disease

Hirotaka Iwaki, Rina Ando, Satoshi Tada et al. · Journal of the Neurological Sciences · 2020 · 23 citations

Pain Therapy, Interventional Pain Medicine, Health Sciences +11